scholarly article | Q13442814 |
P819 | ADS bibcode | 1998PNAS...9510224G |
P356 | DOI | 10.1073/PNAS.95.17.10224 |
P932 | PMC publication ID | 21489 |
P698 | PubMed publication ID | 9707628 |
P5875 | ResearchGate publication ID | 13576941 |
P2093 | author name string | H Goto | |
Y Kawaoka | |||
P2860 | cites work | The 2.2 A resolution crystal structure of influenza B neuraminidase and its complex with sialic acid | Q27644309 |
Rapid and efficient site-specific mutagenesis without phenotypic selection | Q27860628 | ||
Efficient selection for high-expression transfectants with a novel eukaryotic vector | Q27860810 | ||
Characterization of temperature sensitive influenza virus mutants defective in neuraminidase | Q27865285 | ||
Initial genetic characterization of the 1918 "Spanish" influenza virus | Q28305563 | ||
Cloning, sequence analysis, and expression in Escherichia coli of a streptococcal plasmin receptor | Q30983878 | ||
Structure of the influenza virus glycoprotein antigen neuraminidase at 2.9 A resolution | Q34271513 | ||
The outer surface protein A of the spirochete Borrelia burgdorferi is a plasmin(ogen) receptor | Q35993610 | ||
Biologic importance of neuraminidase stalk length in influenza A virus | Q36640894 | ||
Glycosylation of neuraminidase determines the neurovirulence of influenza A/WSN/33 virus | Q36654449 | ||
The kidney is a major site of alpha(2)-antiplasmin production | Q37355545 | ||
Virulence factors of influenza A viruses: WSN virus neuraminidase required for plaque production in MDBK cells | Q37507086 | ||
The neuraminidase of influenza virus | Q38211862 | ||
Enhancement of the infectivity of influenza A and B viruses by proteolytic cleavage of the hemagglutinin polypeptide | Q39752742 | ||
Activation of influenza A viruses by trypsin treatment | Q39965584 | ||
The sequence of the nucleoprotein gene of human influenza A virus, strain A/NT/60/68 | Q40492809 | ||
Capturing host plasmin(ogen): a common mechanism for invasive pathogens? | Q40742856 | ||
Host cell proteases controlling virus pathogenicity | Q40742881 | ||
Role of cell-surface lysines in plasminogen binding to cells: identification of .alpha.-enolase as a candidate plasminogen receptor | Q41695669 | ||
Proteolytic cleavage by plasmin of the HA polypeptide of influenza virus: host cell activation of serum plasminogen | Q43792248 | ||
Replication of influenza virus in a continuous cell line: high yield of infective virus from cells inoculated at high multiplicity | Q45233319 | ||
Cell tropism of influenza virus mediated by hemagglutinin activation at the stage of virus entry | Q45780778 | ||
Cellular receptors in the regulation of plasmin generation | Q70943424 | ||
P433 | issue | 17 | |
P407 | language of work or name | English | Q1860 |
P921 | main subject | influenza A virus | Q834390 |
P1104 | number of pages | 5 | |
P304 | page(s) | 10224-10228 | |
P577 | publication date | 1998-08-01 | |
P1433 | published in | Proceedings of the National Academy of Sciences of the United States of America | Q1146531 |
P1476 | title | A novel mechanism for the acquisition of virulence by a human influenza A virus | |
P478 | volume | 95 |
Q35967598 | 1918 Spanish influenza: the secrets remain elusive |
Q29642855 | A DNA transfection system for generation of influenza A virus from eight plasmids |
Q30332855 | A molecular mechanism for the low‐pH stability of sialidase activity of influenza A virus N2 neuraminidases1 |
Q26753030 | Aberrant coagulation causes a hyper-inflammatory response in severe influenza pneumonia |
Q37049959 | Accurate Measurement of the Effects of All Amino-Acid Mutations on Influenza Hemagglutinin |
Q38118946 | Activation of influenza viruses by proteases from host cells and bacteria in the human airway epithelium |
Q41902309 | Amelioration of influenza virus pathogenesis in chickens attributed to the enhanced interferon-inducing capacity of a virus with a truncated NS1 gene. |
Q33624624 | An enzymatic virus-like particle assay for sensitive detection of virus entry |
Q33923545 | An experimentally determined evolutionary model dramatically improves phylogenetic fit. |
Q39764324 | Annexin II incorporated into influenza virus particles supports virus replication by converting plasminogen into plasmin |
Q74489921 | Anti-influenza drugs and neuraminidase inhibitors |
Q36679637 | Anti-influenza virus agents: synthesis and mode of action |
Q39682951 | Apical budding of a recombinant influenza A virus expressing a hemagglutinin protein with a basolateral localization signal |
Q27863797 | Assembly and budding of influenza virus |
Q33862671 | Bacillus anthracis interacts with plasmin(ogen) to evade C3b-dependent innate immunity |
Q33644708 | Biological heterogeneity, including systemic replication in mice, of H5N1 influenza A virus isolates from humans in Hong Kong |
Q39611736 | Budding capability of the influenza virus neuraminidase can be modulated by tetherin |
Q41039054 | Canine distemper virus and measles virus fusion glycoprotein trimers: partial membrane-proximal ectodomain cleavage enhances function |
Q43698426 | Changes in calcium currents and GABAergic spontaneous activity in cultured rat hippocampal neurons after a neurotropic influenza A virus infection |
Q34068624 | Characterization of Variations in PB2, NS1, M, Neuraminidase and Hemagglutinin of Influenza A (H3N2) Viruses in Iran |
Q30357518 | Characterization of an influenza A H5N2 reassortant as a candidate for live-attenuated and inactivated vaccines against highly pathogenic H5N1 viruses with pandemic potential. |
Q33908690 | Chimeric influenza virus hemagglutinin proteins containing large domains of the Bacillus anthracis protective antigen: protein characterization, incorporation into infectious influenza viruses, and antigenicity |
Q39684429 | Cleavage of influenza a virus hemagglutinin in human respiratory epithelium is cell associated and sensitive to exogenous antiproteases |
Q30386796 | Cleavage of influenza virus hemagglutinin by airway proteases TMPRSS2 and HAT differs in subcellular localization and susceptibility to protease inhibitors |
Q30385853 | Computational analysis and determination of a highly conserved surface exposed segment in H5N1 avian flu and H1N1 swine flu neuraminidase |
Q30342476 | Confronting the avian influenza threat: vaccine development for a potential pandemic. |
Q36324044 | Deep mutational scanning identifies sites in influenza nucleoprotein that affect viral inhibition by MxA |
Q30354020 | Determinants of virulence of influenza A virus. |
Q56556444 | Effect of annexin II-mediated conversion of plasmin from plasminogen on airborne transmission of H9N2 avian influenza virus |
Q40551696 | Efficient generation and growth of influenza virus A/PR/8/34 from eight cDNA fragments |
Q34291692 | Emergence of fatal avian influenza in New England harbor seals |
Q34332728 | Enhancing the proteolytic maturation of human immunodeficiency virus type 1 envelope glycoproteins |
Q52720764 | Enterokinase Enhances Influenza A Virus Infection by Activating Trypsinogen in Human Cell Lines. |
Q38765568 | Evidence that Receptor Destruction by the Sendai Virus Hemagglutinin-Neuraminidase Protein Is Responsible for Homologous Interference |
Q56986210 | Evolution of high pathogenicity of H5 avian influenza virus: haemagglutinin cleavage site selection of reverse-genetics mutants during passage in chickens |
Q42256828 | Evolutionarily conserved residues at an oligomerization interface of the influenza A virus neuraminidase are essential for viral survival |
Q30328377 | Experimenting on the past: the enigma of von Economo's encephalitis lethargica. |
Q35596522 | Features of two new proteins with OmpA-like domains identified in the genome sequences of Leptospira interrogans |
Q36467525 | From touchdown to transcription: the reovirus cell entry pathway |
Q30422593 | Fully human broadly neutralizing monoclonal antibodies against influenza A viruses generated from the memory B cells of a 2009 pandemic H1N1 influenza vaccine recipient |
Q30356237 | Functional and antigenic analyses of the 1918 influenza virus haemagglutinin using a recombinant vaccinia virus expression system. |
Q40297734 | Gangliosides are not essential for influenza virus infection |
Q45748115 | Genetic analysis of mouse-adapted influenza A virus identifies roles for the NA, PB1, and PB2 genes in virulence |
Q38122284 | Genetic changes that accompanied shifts of low pathogenic avian influenza viruses toward higher pathogenicity in poultry |
Q42596462 | Genetic diversity in the yellow head nidovirus complex |
Q30342658 | Global host immune response: pathogenesis and transcriptional profiling of type A influenza viruses expressing the hemagglutinin and neuraminidase genes from the 1918 pandemic virus. |
Q27317087 | H1N1 influenza virus induces narcolepsy-like sleep disruption and targets sleep-wake regulatory neurons in mice |
Q35661091 | H4N8 subtype avian influenza virus isolated from shorebirds contains a unique PB1 gene and causes severe respiratory disease in mice |
Q40483839 | High permissivity of human HepG2 hepatoma cells for influenza viruses. |
Q39149977 | Human airway trypsin-like protease, a serine protease involved in respiratory diseases |
Q30369081 | Human infection with highly pathogenic H5N1 influenza virus. |
Q73890457 | Human influenza A viruses are proteolytically activated and do not induce apoptosis in CACO-2 cells |
Q34552726 | Identification of critical residues of influenza neuraminidase in viral particle release |
Q33617807 | In vitro identification of novel plasminogen-binding receptors of the pathogen Leptospira interrogans |
Q30416440 | In vitro passaging of a pandemic H1N1/09 virus selects for viruses with neuraminidase mutations conferring high-level resistance to oseltamivir and peramivir, but not to zanamivir |
Q30379268 | Infection with a Mouse-Adapted Strain of the 2009 Pandemic Virus Causes a Highly Severe Disease Associated with an Impaired T Cell Response. |
Q40540874 | Influenza A Virus Hemagglutinin is Required for the Assembly of Viral Components Including Bundled vRNPs at the Lipid Raft |
Q34405097 | Influenza A virus does not encode a tetherin antagonist with Vpu-like activity and induces IFN-dependent tetherin expression in infected cells |
Q30427818 | Influenza HA subtypes demonstrate divergent phenotypes for cleavage activation and pH of fusion: implications for host range and adaptation |
Q33804501 | Influenza virus assembly and lipid raft microdomains: a role for the cytoplasmic tails of the spike glycoproteins |
Q24634155 | Influenza virus hemagglutinin cleavage into HA1, HA2: no laughing matter |
Q30305461 | Influenza virus neuraminidase inhibitors |
Q44408154 | Influenza virus virulence and its molecular determinants |
Q34360974 | Influenza virus-mediated membrane fusion: determinants of hemagglutinin fusogenic activity and experimental approaches for assessing virus fusion |
Q91853596 | Influenza's Newest Trick |
Q37071008 | Influenza: the virus and prophylaxis with inactivated influenza vaccine in "at risk" groups, including COPD patients |
Q34556193 | Inhibition of lung serine proteases in mice: a potentially new approach to control influenza infection |
Q45743666 | Intergenic HA-NA interactions in influenza A virus: postreassortment substitutions of charged amino acid in the hemagglutinin of different subtypes |
Q47210087 | Internal genes of a highly pathogenic H5N1 influenza virus determine high viral replication in myeloid cells and severe outcome of infection in mice. |
Q30233673 | Interspecies transmission of influenza viruses: H5N1 virus and a Hong Kong SAR perspective. |
Q45710608 | Invasion and Persistence of the Neuroadapted Influenza Virus A/WSN/33 in the Mouse Olfactory System |
Q36381404 | Involvement of non-structural proteins (NS) in influenza A infection and viral tropism |
Q35036111 | Leptospira interrogans enolase is secreted extracellularly and interacts with plasminogen |
Q30424187 | Matriptase, HAT, and TMPRSS2 activate the hemagglutinin of H9N2 influenza A viruses |
Q28143090 | Maturation of HIV envelope glycoprotein precursors by cellular endoproteases |
Q43612047 | Mini-plasmin found in the epithelial cells of bronchioles triggers infection by broad-spectrum influenza A viruses and Sendai virus |
Q41357037 | Modification of the hemagglutinin cleavage site allows indirect activation of avian influenza virus H9N2 by bacterial staphylokinase |
Q34055445 | Modifications to the hemagglutinin cleavage site control the virulence of a neurotropic H1N1 influenza virus |
Q37658537 | Modulation of an ectodomain motif in the influenza A virus neuraminidase alters tetherin sensitivity and results in virus attenuation in vivo |
Q33787373 | Molecular correlates of influenza A H5N1 virus pathogenesis in mice |
Q30364868 | Molecular determinants of influenza virus pathogenesis in mice. |
Q33832053 | Molecular mechanisms of plasminogen activation: bacterial cofactors provide clues |
Q43173140 | Multiple genes contribute to the virulent phenotype observed in ferrets of an H5N1 influenza virus isolated from Thailand in 2004. |
Q33819172 | Mutation of neuraminidase cysteine residues yields temperature-sensitive influenza viruses |
Q34263939 | Neuropathogenesis of influenza virus infection in mice |
Q77407876 | New clues to the emergence of flu pandemics |
Q37772440 | Novel insights into proteolytic cleavage of influenza virus hemagglutinin |
Q30350342 | Novel strategies for prevention and treatment of influenza. |
Q37127980 | Nucleotide sequence requirements at the 5' end of the influenza A virus M RNA segment for efficient virus replication |
Q36497143 | PAR1 contributes to influenza A virus pathogenicity in mice |
Q22299330 | Pandemic Threat Posed by Avian Influenza A Viruses |
Q30326778 | Pandemic influenza is a zoonosis, as it requires introduction of avian-like gene segments in the human population. |
Q56426947 | Pathogenesis and Pathogenicity of Influenza Viruses |
Q30339011 | Pathogenicity and immunogenicity of influenza viruses with genes from the 1918 pandemic virus. |
Q30351800 | Pathogenicity of influenza viruses with genes from the 1918 pandemic virus: functional roles of alveolar macrophages and neutrophils in limiting virus replication and mortality in mice |
Q36523231 | Permissive and restricted virus infection of murine embryonic stem cells |
Q45731479 | Persistence of viral RNA in the brain of offspring to mice infected with influenza A/WSN/33 virus during pregnancy |
Q39511229 | Plasmin-coated borrelia Burgdorferi degrades soluble and insoluble components of the mammalian extracellular matrix |
Q30427707 | Plasmin-mediated activation of pandemic H1N1 influenza virus hemagglutinin is independent of the viral neuraminidase. |
Q41853863 | Plasminogen acquisition and activation at the surface of leptospira species lead to fibronectin degradation |
Q27335814 | Plasminogen controls inflammation and pathogenesis of influenza virus infections via fibrinolysis |
Q39604149 | Plasminogen-binding activity of neuraminidase determines the pathogenicity of influenza A virus |
Q30388799 | Postreassortment amino acid substitutions in influenza A viruses |
Q30369896 | Progress in identifying virulence determinants of the 1918 H1N1 and the Southeast Asian H5N1 influenza A viruses. |
Q30436323 | Protection afforded by intranasal immunization with the neuraminidase-lacking mutant of influenza A virus in a ferret model |
Q37127965 | Proteolytic activation of the 1918 influenza virus hemagglutinin |
Q33701942 | Reverse genetics of negative-strand RNA viruses: closing the circle |
Q40815232 | Role of transmembrane domain and cytoplasmic tail amino acid sequences of influenza a virus neuraminidase in raft association and virus budding |
Q30351350 | Sialidase activity of influenza A virus in an endocytic pathway enhances viral replication. |
Q34057785 | Single-domain antibodies targeting neuraminidase protect against an H5N1 influenza virus challenge |
Q39755380 | Subcellular localization and calcium and pH requirements for proteolytic processing of the Hendra virus fusion protein |
Q43170636 | Surviving another influenza threat |
Q30354127 | Switch from protective to adverse inflammation during influenza: viral determinants and hemostasis are caught as culprits. |
Q37713993 | TMPRSS2 is a host factor that is essential for pneumotropism and pathogenicity of H7N9 influenza A virus in mice |
Q37252750 | TMPRSS2 is an activating protease for respiratory parainfluenza viruses. |
Q30327942 | The 1918 Spanish influenza: integrating history and biology. |
Q35974128 | The Hemagglutinin of Bat-Associated Influenza Viruses Is Activated by TMPRSS2 for pH-Dependent Entry into Bat but Not Human Cells |
Q54691269 | The Pandemic Threat of Avian Influenza Viruses |
Q44630447 | The cleavage activation and sites of glycosylation in the fusion protein of Hendra virus |
Q33959377 | The emergence of novel swine influenza viruses in North America |
Q37011494 | The human/animal interface: emergence and resurgence of zoonotic infectious diseases |
Q92527298 | The inducible amphisome isolates viral hemagglutinin and defends against influenza A virus infection |
Q33943327 | The inherent mutational tolerance and antigenic evolvability of influenza hemagglutinin |
Q30397306 | The low-pH stability discovered in neuraminidase of 1918 pandemic influenza A virus enhances virus replication |
Q30328490 | The pathogenesis of influenza in humans. |
Q33803192 | The role of alpha/beta and gamma interferons in development of immunity to influenza A virus in mice |
Q30361549 | The threat of avian influenza A (H5N1). Part I: Epidemiologic concerns and virulence determinants. |
Q33594360 | Understanding influenza virus pathogenicity |
Q30379985 | Use of animal models to understand the pandemic potential of highly pathogenic avian influenza viruses. |
Q33793144 | Use of the plasminogen activation system by microorganisms |
Q52625014 | Variation at extra-epitopic amino acid residues influences suppression of influenza virus replication by M158-66 epitope-specific CD8+ T lymphocytes. |
Q43209319 | Who's that lady? |
Q74800577 | [Factors affecting the virulence and pathogenicity of avian and human viral strains (influenza virus type A)] |
Search more.